Abstract
The recent application of monoclonal antibody stains to Mohs micrographic surgery may lead to increased accuracy in the excision of certain difficult tumours. Immunohistochemical techniques may also increase the range of tumours regularly treated by Mohs surgery. The concept is very much in its infancy, and controlled trials with long-term follow-up are required before the real worth of the process can be evaluated.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
